Myeloproliferative Disorders Drugs/Treatment Market size was valued at USD 9.3 billion in 2023 and is expected to grow at a CAGR of 3.2% between 2024 and 2032....
Sodium Hyaluronate-Based Products Market size was valued at around USD 11.3 billion in 2023 and is anticipated to register a CAGR of 7.8% between 2024 and 2032. ...
Abortion Drugs Market size was valued at over USD 24.42 billion in 2023 and is estimated to grow at 8.2% CAGR from 2024-2032, reaching over USD 49.27 billion by 2032. ...
Aesthetic Injectables Market was valued at USD 13.2 billion in 2023 and is anticipated to showcase a growth of 10.2% to reach USD 31.3 billion by 2032. ...
Antiparasitic Drugs Market was valued at USD 22.7 billion in 2023 and is estimated to grow at a CAGR of 5.7% between 2024 and 2032 to reach USD 37 billion by 2032. ...
The ophthalmology drugs market size was valued at USD 31 billion in 2023 and is expected to reach USD 49.4 billion in 2032 with a CAGR of 5.1% from 2024 to 2032 owing to Increasing prevalence of eye disorders. ...
U.S Peptide Therapeutics Market was valued to be around USD 17.8 billion in 2022 and is projected to witness massive growth at a CAGR of around 7% from 2023 to 2032. ...
Postmenopausal Osteoporosis Treatment Market size accounted for around USD 7.6 billion in 2022 and is expected to reach USD 11.6 billion by 2032 due to the increasing adoption of highly efficient treatments for postmenopausal osteoporosis. ...
Tramadol Drug Market size was valued to be USD 4.5 billion in 2022 and is expected to reach USD 8.6 billion in 2032, growing at a CAGR of 6.8% from 2023 to 2032. ...
Sleep Medications Market size was valued to be USD 21.5 billion in 2023 and is predicted to experience a sustainable development of CAGR 6.8% by 2032....
Regenerative Medicine Market size is valued to be USD 52.3 billion in 2022 and is projected to grow at CAGR of 20.4% and reach USD 328.9 billion by 2032. ...
Injectable Contraceptives Market size was valued to be USD 339.5 million in 2022 and is predicted to experience a sustainable growth of CAGR 3.5% from 2023 to 2032. ...
Organ Transplant Rejection Medication Market size in 2022 was valued at USD 5.5 billion and is expected to witness growth at CAGR of 3.2% and reach USD 7.5 billion by 2032. ...
Muscle Relaxant Drugs Market size was valued to be USD 4.1 billion in 2022 and is expected to reach USD 9.4 billion in 2032 with a CAGR of 6.4% from 2023 to 2032. ...
Intravenous Immunoglobulin (IVIG) Market size is estimated to have reached USD 10.9 billion in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032. ...
Antibiotic Resistance Market size is valued to be USD 8.2 billion in 2022 and is projected to grow at CAGR of 5.3% and reach USD 13.6 billion by 2032. ...
Biosimilars Market size was worth more than USD 35 billion in 2022 and is poised to witness substantial growth at 13% CAGR from 2023 to 2032 driven by the high prevalence of chronic diseases globally....
Dermatology Drugs Market size was valued to be USD 27.1 billion in 2022 and is expected to reach USD 73.5 billion in 2032 with a CAGR of 10.5% from 2023 to 2032. ...
Pain Management Drugs Market size was valued to be USD 70.1 billion in 2022 and is expected to reach USD 108.9 billion in 2032 with a CAGR of 4.5% by 2032 ...
Central Nervous System Therapeutics Market size was anticipated to be worth USD 110.4 billion in 2022 and is expected to reach USD 238.8 billion by 2032...
Viscosupplementation Market size was worth USD 3.6 billion in 2022. Driven by the high prevalence of osteoarthritis among the aging population, the industry is poised to record more than 9% CAGR from 2023 to 2032....
Antibody Drug Conjugates Market size accounted for USD 7.7 billion in 2023 and is estimated to grow at CAGR of 14.8% to reach USD 26.6 billion by 2032....